Long-term stability of acquired drug resistance and resistance associated mutations in the fungal pathogen Nakaseomyces glabratus (Candida glabrata)

  22 August 2024

The increasing number of fungal isolates showing drug or multidrug resistance poses a significant medical threat. Several yeast pathogens, like Nakaseomyces glabratus, can develop drug resistance through genetic mutations. The stability of acquired drug resistance is crucial for understanding the appearance and spread of drug-resistant outbreaks and defining effective strategies. An in vitro evolution approach was used to assess the stability of resistance phenotypes and mutations acquired from antifungal exposure. Results showed remarkable stability in several evolved populations, with anidulafungin resistance showing higher stability than fluconazole resistance. Novel mutations in previously altered resistance-associated genes were detected, suggesting a possible compensatory role. Acquired resistance, particularly to anidulafungin, is a long-lasting phenotype with significant implications for drug-resistant clinical outbreaks.

Author(s): Ewa Ksiezopolska et al
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed